Characterization of the inhibitory effect of an extract of Prunella vulgaris on Ebola virus glycoprotein (GP)-mediated virus entry and infection

Currently, no approved antiviral therapeutic is available for treatment or prevention of Ebola virus (EBOV) infection. In this study, we characterized an EBOV-glycoprotein (GP) pseudotyped HIV-1-based vector system in different cell cultures, including human umbilical vein endothelial cells (HUVECs)...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Xu, Ao, Zhujun, Bello, Alexander, Ran, Xiaozhuo, Liu, Shuiping, Wigle, Jeffrey, Kobinger, Gary, Yao, Xiaojian
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier B.V. 2016
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7113790/
https://www.ncbi.nlm.nih.gov/pubmed/26778707
http://dx.doi.org/10.1016/j.antiviral.2016.01.001

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7113790/
https://www.ncbi.nlm.nih.gov/pubmed/26778707
http://dx.doi.org/10.1016/j.antiviral.2016.01.001

Ejemplares similares